Comparing the efficacy of Amritadi Guggulu and Vyoshadi Guggulu after Virechana (Therapeutic Purgation) in patients of Medoroga (Dyslipidemia)
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/02/039995
- Lead Sponsor
- All India Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patient with Pratyatma Lakshan of Medoroga
Patient fulfilling the Diagnostic Criteria of Dyslipidemia
Patients of Age group between 21 to 50 years irrespective of gender, caste, creed and body weight
Patients fit for Virechana karma
Patient willing and able to give written consent in the study
Patients with poorly controlled Diabetes Mellitus (HbA1c >10%) and Hypertension ( BP > 160 / 100 mm Hg)
Pregnant / lactating woman
Patients with genetic syndromes, severe cardiovascular disease or any other life threatening condition.
History of hypersensitivity to any of the trial drugs or their ingredients.
Patients unfit for Virechana karma
Patients having systemic illness which will interfere with the course of procedure.
Patients who are already enrolled in other study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in the Signs and Symptoms of Medoroga <br/ ><br>Change in the haematological parameters of DyslipidemiaTimepoint: Before and After Treatment
- Secondary Outcome Measures
Name Time Method Improvement in the quality of life as assessed with the help of questionnaires for scaling of Quality Of Life (SF 36) <br/ ><br>Changes in Body Mass Index, Skin Fold Thickness (Triceps and Abdomen) and Waist- Hip Ratio.Timepoint: 105 Days